Will AI revolutionise pharmaceutical R&D? Katrina Costa, MA (Oxon), MSc Science Writer, Open Pharma Research Ltd. January 2021 In the last few decades, the generation of big data in the life sciences, coupled with rapid advances in data processing technology, has led to pharma’s interest in the promise of AI. Scientists hope AI will speed…
Why aim for a Connected Lab? Katrina Costa, MA (Oxon), MSc Science Writer, Open Pharma Research Ltd. December 2020 The world is becoming a web of interconnected devices. Our homes are filled with smart technology, robots and voice-activated assistants. The Internet of Things (IoT), with its “Enchanted Objects”, is growing in popularity. The IoT is…
What’s so important about digitalisation anyway? Katrina Costa, MA (Oxon), MSc Science Writer, Open Pharma Research Ltd. December 2020 Yes, life science companies are embracing the power of digital. There is growing realisation that archaic R&D processes need to be disrupted and reengineered in order to deliver much needed medicines for unmet patient needs. However,…